Structure and Drug Screening
Director: Vincent Groppi, Ph.D.
Martha Larsen, M.S., HTS and Cheminformatics, Center for Chemical Genomics
William Clay Brown, Ph.D., HT Cloning and Expression, Center for Structural Biology
Jeanne Stuckey, Ph.D., Center for Structural Biology
Andrew White, Ph.D., Medicinal Chemistry, College of Pharmacy
Ashley Schork, Project Manager
Location: Life Sciences Institute and College of Pharmacy
Structure and Drug Screening offers UMCCC members the requisite expertise and resources to successfully advance their basic research into a clinically relevant, milestone-driven drug discovery project by providing high throughput screening using large chemical libraries, HTS informatics, high throughput gene cloning and protein expression, structural biology and medicinal chemistry.
- To support early-stage, cancer research discovery projects in structural biology, target discovery, small molecule screening and medicinal chemistry -- via unique technical expertise and specialized equipment.
- To support enhanced pre-clinical efforts to develop compounds and compound classes that show considerable promise and potential in early-stage research efforts.